Article

A Randomized, Double-blind, Placebo-controlled Study to Assess QTc Interval Prolongation of Standard Dose Aflibercept in Cancer Patients Treated With Docetaxel

Journal of Cardiovascular Pharmacology, Wolters Kluwer, ISSN 0160-2446

Volume 61, 6, 2013

DOI:10.1097/fjc.0b013e31828b73ff, Dimensions: pub.1041112385, PMID: 23429593,

Affiliations

Organisations

  1. (1) Antwerpen University Hospital, Department of Medical Oncology, Edegem, Belgium;
  2. (2) Ege University, grid.8302.9
  3. (3) Cliniques Universitaires Saint-Luc, grid.48769.34
  4. (4) St. Luke's Hospital, grid.416480.f
  5. (5) Center of Medical Oncology Iasi, Iasi, Romania;
  6. (6) Essen University Hospital, grid.410718.b
  7. (7) Herlev Hospital, grid.411900.d, Capital Region
  8. (8) Institute of Oncology “prof Dr I Chiricuta”, Cluj Napoca, Romania;
  9. (9) Azienda Ospedaliero Universitaria Ospedali Riuniti, grid.411490.9
  10. (10) Universitätsklinik Marien Hospital Herne, grid.459734.8
  11. (11) Istanbul Bilim University, grid.411773.7
  12. (12) Klinikum Mutterhaus der Borromäerinnen, grid.492783.3
  13. (13) Baptist Regional Cancer Institute, Jacksonville, FL; and
  14. (14) Sanofi R&D, R&D Oncology Division, Vitry-sur-Seine, France.

Research Categories

Main Subject Area

Fields of Research

Links & Metrics

NORA University Profiles

University of Copenhagen

Dimensions Citation Indicators

Times Cited: 2

Field Citation Ratio (FCR): 0.34

Relative Citation ratio (RCR): 0.1